References
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71:209–49.
- Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022; 28:1187–203.
- Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019; 14:26–38.
- Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013; 107:230–6.
- Nshizirungu JP, Bennis S, Mellouki I, Sekal M, Benajah DA, Lahmidani N, et al. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) gastric cancer molecular classifications and their association with clinicopatho-logical characteristics and overall survival in Moroccan patients. Dis Markers. 2021; 2021:9980410. doi: 10.1155/2021/9980410
- Yang L, Ying X, Liu S, Lyu G, Xu Z, Zhang X, et al. Gastric cancer: epidemiology, risk factors and prevention strategies. Chin J Cancer Res. 2020; 32:695–704.
- He CY, Qiu MZ, Yang XH, Zhou DL, Ma JJ, Long YK, et al. Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosis. Clin Transl Med. 2020; 10:353–62.
- Park HJ, Kim HS, Kim JW, Park SY, Kim BR, Ryu HY, et al. Is microsatellite instability (MSI) associated with multiplicity in early stage gastric neoplasias? Clin Res Hepatol Gastroenterol. 2013; 37:400–5.
- Puliga E, Corso S, Pietrantonio F, Giordano S. Microsatellite instability in gastric cancer: between lights and shadows. Cancer Treat Rev. 2021; 95:102175.
- Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023; 16:57.
- Zeng D, Wu J, Luo H, Li Y, Xiao J, Peng J, et al. Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer. J Immunother Cancer. 2021; 9:e002467.
- Liu L, Niu L, Zheng X, Xiao F, Sun H, Deng W, et al. PD-L1 expression-related PI3K pathway correlates with immunotherapy efficacy in gastric cancer. Ther Adv Med Oncol. 2023; 15:17588359231205853.
- Wang Z, Wang X, Xu Y, Li J, Zhang X, Peng Z, et al. Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma. BMC Med. 2022; 20:133.
- Marijt KA, Sluijter M, Blijleven L, Tolmeijer SH, Scheeren FA, van der Burg SH, et al. Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling. J Immunother Cancer. 2019; 7:152.
- Luchini C, Bibeau F, Ligtenberg MJL, Singh N, Nottegar A, Bosse T, et al. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol. 2019; 30:1232–43.
- Sun K, Jia K, Lv H, Wang SQ, Wu Y, Lei H, et al. EBV-positive gastric cancer: current knowledge and future perspectives. Front Oncol. 2020; 10:583463.
- Zeng D, Li M, Zhou R, Zhang J, Sun H, Shi M, et al. Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures. Cancer Immunol Res. 2019; 7:737–50.
- Watanabe H, Enjoji M, Imai T. Gastric carcinoma with lymphoid stroma. Its morphologic characteristics and prognostic correlations. Cancer. 1976; 38:232–43.
- Burke AP, Yen TS, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein–Barr virus demonstrated by polymerase chain reaction. Mod Pathol. 1990; 3:377–80.
- Kang W, To KF. Are Epstein–Barr Virus-positive and -negative gastric carcinomas, with lymphoid stroma, single entity or different entities? Clin Gastroenterol Hepatol. 2015; 13:1745–7.
- Sun Q, Fu Y, Chen X, Li L, Wu H, Liu Y, et al. Prognostic perspectives of STING and PD-L1 expression and correlation with the prognosis of Epstein–Barr Virus-associated gastric cancers. Gut Liver. 2022; 16:875–91.
- Noh JH, Shin JY, Lee JH, Park YS, Lee IS, Kim GH, et al. Clinical significance of Epstein–Barr virus and Helicobacter pylori infection in gastric carcinoma. Gut Liver. 2023; 17:69–77.
- Kwak Y, Seo AN, Lee HE, Lee HS. Tumor immune response and immunotherapy in gastric cancer. J Pathol Transl Med. 2020; 54:20–33.